SEC Form 4/A · accession 0001437749-17-012084
CervoMed Inc. · CRVO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
John Gainer
Officer — Chief Scientific Officer · Director
Period of report
May 10, 2017
Accepted (ET)
Jun 30, 2017 · 4:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001053691
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $2.96 | May 10, 2017 | A | 34,000 | A | — | May 10, 2027 | Common Stock | 34,000 | 34,000 | D |
Explanation of responses
- F1The shares underlying the options vest in equal parts on the last calendar day of each month until fully vested on May 31, 2020.
Remarks
This amendment is being filed solely to correct an error in the reported exercise price of the Derivative Security in the original filing.